Mutation-Directed Therapeutics for Neurofibromatosis Type I

Andre Leier; David M Bedwell; Ann T Chen; George Dickson; Kim M Keeling; Robert A Kesterson; Bruce R Korf; Tatiana T Marquez Lago; Ulrich F Müller; Linda Popplewell; Jiangbing Zhou; Deeann Wallis

doi:10.1016/j.omtn.2020.04.012

Mutation-Directed Therapeutics for Neurofibromatosis Type I

Andre Leier, David M Bedwell, Ann T Chen, George Dickson, Kim M Keeling, Robert A Kesterson, Bruce R Korf, Tatiana T Marquez Lago, Ulrich F Müller, Linda Popplewell, Jiangbing Zhou, Deeann Wallis

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	739-753
Number of pages	15
Journal	Molecular therapy. Nucleic acids
Volume	20
DOIs	https://doi.org/10.1016/j.omtn.2020.04.012
Publication status	Published - 5 Jun 2020

Access to Document

10.1016/j.omtn.2020.04.012

Cite this

@article{374c4989074d448e8d8ec55e5396604b,

title = "Mutation-Directed Therapeutics for Neurofibromatosis Type I",

author = "Andre Leier and Bedwell, {David M} and Chen, {Ann T} and George Dickson and Keeling, {Kim M} and Kesterson, {Robert A} and Korf, {Bruce R} and {Marquez Lago}, {Tatiana T} and M{\"u}ller, {Ulrich F} and Linda Popplewell and Jiangbing Zhou and Deeann Wallis",

note = "Copyright {\textcopyright} 2020. Published by Elsevier Inc.",

year = "2020",

month = jun,

day = "5",

doi = "10.1016/j.omtn.2020.04.012",

language = "English",

volume = "20",

pages = "739--753",

journal = "Molecular therapy. Nucleic acids",

issn = "2162-2531",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Mutation-Directed Therapeutics for Neurofibromatosis Type I

AU - Leier, Andre

AU - Bedwell, David M

AU - Chen, Ann T

AU - Dickson, George

AU - Keeling, Kim M

AU - Kesterson, Robert A

AU - Korf, Bruce R

AU - Marquez Lago, Tatiana T

AU - Müller, Ulrich F

AU - Popplewell, Linda

AU - Zhou, Jiangbing

AU - Wallis, Deeann

PY - 2020/6/5

Y1 - 2020/6/5

U2 - 10.1016/j.omtn.2020.04.012

DO - 10.1016/j.omtn.2020.04.012

M3 - Review article

C2 - 32408052

SN - 2162-2531

VL - 20

SP - 739

EP - 753

JO - Molecular therapy. Nucleic acids

JF - Molecular therapy. Nucleic acids

ER -